MC

Meenakshi Chidambaram

Director DIN 06492618
DIN 06492618 First appointment Feb 2013
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Meenakshi Chidambaram

Data last updated:

Meenakshi Chidambaram was a Director at Ruma Biotherapy And Research Centre Private Limited (from 2013) and Director at Mkv Organics Private Limited (from 2014).

DIN 06492618
First Appointment 25 Feb 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Feb 20132013Strike Off
Mkv Organics Private Limited U15137PY2014PTC002874
Director21 Mar 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ruma Biotherapy And Research Centre Private Limited
Mkv Organics Private Limited
Premium access

Shareholding and investment profile for Meenakshi Chidambaram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenakshi Chidambaram

Meenakshi Chidambaram was first appointed on 25 Feb 2013 as Director at Ruma Biotherapy And Research Centre Private Limited. The most recent appointment on record is 21 Mar 2014 at Mkv Organics Private Limited.

Meenakshi Chidambaram held 2 earlier board appointments: Ruma Biotherapy And Research Centre Private Limited (Director, from 25 Feb 2013); Mkv Organics Private Limited (Director, from 21 Mar 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available